Evidence based medicine and pharmacoeconomics

Unfortunatelly, the exact cost-reduction can not be calculated due to the type of reduction
(mainly qualitative reduction, meaning time consuming, health benefit for the baby etc). The
credibility of pharmacoeconomics lies in developing studies in accordance with generally
applicable standards of analysis and interpretation. Then users can translate pharmacoeconomic
research findings into practices to ensure that decision makers allocate scarce health care
resources wisely, fairly, and efficiently.
4

Moving toward more evidence-based practice has the potential to improve quality and safety
while simultaneously reducing costs, thus improving the outcomes of the Pharmacoeconomics.
This field of the pharmacotherapy becomes increasingly important in terms of patient safety and
national cost saving, thus enabling the relevant authorities to reallocate the resources.